Loading
Preparing live trade intelligence...
Loading
Preparing live trade intelligence...
Loading
Loading search results...
Real-time customs records from 4 countries
Russia's imports of trastuzumab reveal evolving trade dynamics, including sourcing patterns, demand shifts, and supplier relationships. Leveraging shipment-level customs data, the insights remain both accurate and up to date.
From 01 Apr 2024 to 31 Mar 2025, the country recorded 31 shipments, supported by active importers and overseas suppliers.
Imports were largely driven by suppliers from China, Belgium, and Germany, pointing to strong trade ties and expanding sourcing strategies.
Total Shipments
31
↑ +8.3% vs last periodTotal Value (USD)
$60.3M
↑ +12.1% vs last period10 shipments shown
| Date | HS Code | Product | Destination | Qty | Value | Importer | Exporter | Actions |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2025 | 3002150000 | Medicinal Products For Retail Sale: (vital And Essential Drugs) Trazimera (trastuzumab) [l... | RUSSIA | $5,634,973 | ||||
| Mar 20, 2025 | 3002150000 | Medicinal Product For Retail Sale: Fesgor (pertuzumab + Trastuzumab) Solution For Subcutan... | RUSSIA | |||||
| Feb 3, 2025 | 3002150000 | Medicinal Product For Retail Sale, (ved, V1): Herceptin (trastuzumab) [lyophilisate For Th... | RUSSIA | |||||
| Feb 3, 2025 | 3002150000 | Medicinal Product For Retail Sale, (ved, V1): Herceptin (trastuzumab) [lyophilizate For Pr... | RUSSIA | $1,247,174 | ||||
| Feb 3, 2025 | 3002150000 | Medicinal Product For Retail Sale: Fesgor (pertuzumab + Trastuzumab) Solution For Subcutan... | RUSSIA | |||||
| Jan 28, 2025 | 3002150000 | C24146 Trastuzumab Emtansine, Substance-solution, Intended For Expertise Of Unregistered M... | RUSSIA | |||||
| Jan 23, 2025 | 3002150000 | C24146 Trastuzumab Emtansine, Lyophilisate, 100 Mg, Intended For Examination Of Unregister... | RUSSIA | $13,490 | ||||
| Jan 19, 2025 | 3002150000 | Trastuzumab Deruxtecan, Lyophilisate, 100 Mg, Not For Veterinary Use, Intended For Examina... | RUSSIA | |||||
| Dec 26, 2024 | 3002150000 | Ip281 Ds/trastuzumab Deruxtecan, Solution Substance, Is Intended For Expertise Of Unregist... | RUSSIA | |||||
| Nov 20, 2024 | 3002150000 | C24146 Trastuzumab Emtansine, Lyophilisate, Intended For Examination Of Unregistered Drugs... | RUSSIA | $3,559 |
Get deeper insights with advanced filters, company profiles, and data exports.
See how our platform transforms your trade intelligence operations with a live walkthrough.
Book a DemoDownload a free sample dataset and explore the full depth of our global trade data.